Polyvinyl Alcohol-Chitosan Scaffold for Tissue Engineering and Regenerative Medicine Application: A Review

Mar Drugs. 2023 May 17;21(5):304. doi: 10.3390/md21050304.

Abstract

Tissue engineering and regenerative medicine (TERM) holds great promise for addressing the growing need for innovative therapies to treat disease conditions. To achieve this, TERM relies on various strategies and techniques. The most prominent strategy is the development of a scaffold. Polyvinyl alcohol-chitosan (PVA-CS) scaffold emerged as a promising material in this field due to its biocompatibility, versatility, and ability to support cell growth and tissue regeneration. Preclinical studies showed that the PVA-CS scaffold can be fabricated and tailored to fit the specific needs of different tissues and organs. Additionally, PVA-CS can be combined with other materials and technologies to enhance its regenerative capabilities. Furthermore, PVA-CS represents a promising therapeutic solution for developing new and innovative TERM therapies. Therefore, in this review, we summarized the potential role and functions of PVA-CS in TERM applications.

Keywords: chitosan; polyvinyl alcohol; regenerative medicine; scaffold; tissue engineering.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials
  • Chitosan*
  • Polyvinyl Alcohol
  • Regenerative Medicine
  • Tissue Engineering / methods
  • Tissue Scaffolds

Substances

  • Chitosan
  • Biocompatible Materials
  • Polyvinyl Alcohol

Grants and funding

This research was funded by Ministry of Science, Technology and Innovation (MOSTI), through MOSTI Ted 2 grant number “TEF07211061”.